Splitting vaccines in small dogs may not lower reaction risk

A fresh post from Scott Weese on Worms & Germs is putting a familiar exam-room question back in focus: should veterinarians split vaccines in small dogs to reduce adverse events? His answer is that there’s no solid evidence this helps, and in some cases it may create more risk than benefit. The issue matters because small dogs do have a higher reported rate of post-vaccination adverse events, but the proposed fix that many pet parents ask about, giving less vaccine, isn’t supported by current evidence or guidelines. (wormsandgermsblog.com)

The concern itself isn’t new. A large body of practice experience, plus observational data, has shown that smaller dogs and some breeds are more likely to have vaccine reactions than larger dogs. In a recent JAVMA analysis, adverse events recorded within three days of canine vaccination were associated with smaller weight, breed, and receiving multiple injections. Earlier work and subsequent commentary have also found that each additional vaccine given at a visit can increase risk, particularly in dogs under 10 kg. (pubmed.ncbi.nlm.nih.gov)

What’s changed is that the profession is getting more explicit about how to respond to that risk. Weese argues that “half-dose” vaccination is bad medicine because clinicians don’t know whether lower doses preserve efficacy, and they have no meaningful evidence that reduced doses lower adverse-event risk. In his review, the limited study often cited in support of half-dose vaccination was too small and methodologically weak to guide practice. He also makes a practical point: even if a modest reduction in severe reactions were possible, the absolute benefit would likely be tiny, while the downside could be inadequate protection against preventable disease. (wormsandgermsblog.com)

That position aligns with AAHA guidance. AAHA’s 2022 canine vaccination guidelines, updated for 2024 and highlighted again in 2025, say “split dosing” to reduce vaccine volume is not labeled or advised. At the same time, the guidelines do endorse a different strategy that can easily get blurred in client conversations: reducing the number of different vaccines given at one visit, and spacing visits by at least two weeks when appropriate. AAHA specifically notes this may be especially helpful in small dogs, while also emphasizing that combination vaccines do not appear to carry more adverse-event risk than single-component products simply because they contain multiple antigens. (aaha.org)

The nuance is especially important now that leptospirosis vaccination has moved into the “core” conversation in North American canine practice. AAHA says most dogs in North America should be considered at risk for leptospirosis, including small-breed dogs in urban and suburban settings, and notes that reformulated leptospiral vaccines have a low adverse-event rate. The guidelines still acknowledge that smaller and younger dogs are more likely to have reactions of any type, which is why they recommend starting the initial lepto series at or after 12 weeks of age and being thoughtful about how many vaccines are given at once. (aaha.org)

For veterinary professionals, the practical takeaway is less about saying yes or no to a client request, and more about reframing the conversation. If a pet parent asks to “split vaccines,” the first question is whether they mean splitting the dose or spacing the schedule. The former is off-label and potentially risky, especially for rabies, where Weese warns that issuing documentation after a half-dose could create serious professional and regulatory exposure. The latter, spacing vaccines over multiple visits, may be a defensible and guideline-consistent approach for selected patients, particularly dogs with a prior vaccine reaction history. (wormsandgermsblog.com)

There’s also a broader communication lesson here. Weese and AAHA both emphasize that vaccine adverse events are real but uncommon, and that serious reactions are rare. That gives practices room to acknowledge client concerns without reinforcing vaccine hesitancy. For teams, this means documenting prior reactions carefully, discussing disease risk versus reaction risk, considering premedication only when indicated, and making sure staff can explain why full labeled doses remain the standard even in tiny dogs. (wormsandgermsblog.com)

Why it matters: This is a pharmacology and protocol story, but it’s also a trust story. Small-dog vaccine conversations are often where pet parent anxiety, preventive care standards, and liability intersect. Clinics that can clearly distinguish evidence-based schedule adjustments from unsupported dose reductions will be better positioned to protect patients, maintain compliance, and preserve confidence in vaccination recommendations. That may become even more important as lepto coverage expands and more practices revisit how they structure puppy and annual preventive visits. (aaha.org)

What to watch: The next thing to watch is whether any controlled studies actually test reduced-dose protocols in higher-risk breeds or weight classes; until then, the standard of care remains full labeled doses with individualized timing and vaccine selection when needed. (wormsandgermsblog.com)